Your browser doesn't support javascript.
loading
Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity.
Wallace, David K; Kraker, Raymond T; Freedman, Sharon F; Crouch, Eric R; Bhatt, Amit R; Hartnett, M Elizabeth; Yang, Michael B; Rogers, David L; Hutchinson, Amy K; VanderVeen, Deborah K; Haider, Kathryn M; Siatkowski, R Michael; Dean, Trevano W; Beck, Roy W; Repka, Michael X; Smith, Lois E; Good, William V; Kong, Lingkun; Cotter, Susan A; Holmes, Jonathan M.
Afiliación
  • Wallace DK; Indiana University Department of Ophthalmology, Indianapolis.
  • Kraker RT; Jaeb Center for Health Research, Tampa, Florida.
  • Freedman SF; Duke Eye Center, Durham, North Carolina.
  • Crouch ER; Eastern Virginia Medical School, Norfolk.
  • Bhatt AR; Texas Children's Hospital, Houston.
  • Hartnett ME; John A. Moran Eye Center, Salt Lake City, Utah.
  • Yang MB; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Rogers DL; Pediatric Ophthalmology Associates Inc, Columbus, Ohio.
  • Hutchinson AK; Emory University School of Medicine, Atlanta, Georgia.
  • VanderVeen DK; Boston Children's Hospital, Boston, Massachusetts.
  • Haider KM; Indiana University Department of Ophthalmology, Indianapolis.
  • Siatkowski RM; Dean McGee Eye Institute, University of Oklahoma, Oklahoma City.
  • Dean TW; Jaeb Center for Health Research, Tampa, Florida.
  • Beck RW; Jaeb Center for Health Research, Tampa, Florida.
  • Repka MX; Wilmer Eye Institute, Baltimore, Maryland.
  • Smith LE; Emory University School of Medicine, Atlanta, Georgia.
  • Good WV; Smith-Kettlewell Eye Research Institute, San Francisco, California.
  • Kong L; Baylor College of Medicine, Houston, Texas.
  • Cotter SA; Southern California College of Optometry at Marshall B. Ketchum University, Fullerton.
  • Holmes JM; Mayo Clinic, Rochester, Minnesota.
JAMA Ophthalmol ; 138(6): 698-701, 2020 06 01.
Article en En | MEDLINE | ID: mdl-32324197

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Retinopatía de la Prematuridad / Bevacizumab Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Infant / Male / Newborn Idioma: En Revista: JAMA Ophthalmol Año: 2020 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Retinopatía de la Prematuridad / Bevacizumab Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Infant / Male / Newborn Idioma: En Revista: JAMA Ophthalmol Año: 2020 Tipo del documento: Article